13 May | 2026 Expanding Bevacizumab-Erlotinib Therapy Through Fumarate Hydratase Deficiency Screening and Drug Target Pathway Analysis in Papillary Morphology Metastatic Renal Cell Carcinoma. de Nicolás-Hernández, J, Valdivia, C, Arenas, A, Zaballos, MA , Robledo, M, Rodríguez-Antona, C . Eur Urol (PMID: 42128750) (doi:10.1016/j.eururo.2026.04.026)
3 Sep | 2022 Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer. Zaballos, MA , Acuña-Ruiz, A , Morante, M, Riesco-Eizaguirre, G , Crespo, P , Santisteban, P . Cell Mol Life Sci - 79 (9) : 504 (PMID: 36056964) (doi:10.1007/s00018-022-04530-9)
23 Aug | 2019 In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice. Ramirez-Moya, J , Wert-Lamas, L , Acuña-Ruiz, A , Zaballos, MA , Santisteban, P . J Vis Exp (PMID: 31498304) (doi:10.3791/59322)
1 Jun | 2019 Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer. Zaballos, MA , Acuña-Ruiz, A , Morante, M, Crespo, P , Santisteban, P . Endocr. Relat. Cancer - 26 (6) : R319-R344 (PMID: 30978703) (doi:10.1530/ERC-19-0098)
1 Mar | 2018 TAZ/WWTR1 Mediates the Pulmonary Effects of NKX2-1 Mutations in Brain-Lung-Thyroid Syndrome. Moya, CM , Zaballos, MA , Garzón, L, Luna, C, Simón, R, Yaffe, MB, Gallego, E, Santisteban, P , Moreno, JC. J. Clin. Endocrinol. Metab. - 103 (3) : 839-852 (PMID: 29294041) (doi:10.1210/jc.2017-01241)
1 Nov | 2017 Key signaling pathways in thyroid cancer. Zaballos, MA , Santisteban, P . J. Endocrinol. - 235 (2) : R43-R61 (PMID: 28838947) (doi:10.1530/JOE-17-0266)
2 Aug | 2016 β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation. Sastre-Perona, A , Riesco-Eizaguirre, G , Zaballos, MA , Santisteban, P . Oncotarget - 7 (31) : 49435-49449 (PMID: 27384483) (doi:10.18632/oncotarget.10356)
20 Mar | 2015 The TALE transcription factor homothorax functions to assemble heterochromatin during Drosophila embryogenesis. Zaballos, MA , Cantero, W, Azpiazu, N. PLoS One - 10 (3) : e0120662 (PMID: 25794008) (doi:10.1371/journal.pone.0120662)
1 Jan | 2013 FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis. Zaballos, MA , Santisteban, P . Mol. Endocrinol. - 27 (1) : 50-62 (PMID: 23160481) (doi:10.1210/me.2012-1032)
1 Mar | 2012 DARPP-32 is required for MAPK/ERK signaling in thyroid cells. Chocarro-Calvo, A , Zaballos, MA , Santisteban, P , García-Jiménez, C. Mol. Endocrinol. - 26 (3) : 471-480 (PMID: 22301787) (doi:10.1210/me.2011-1309)
1 May | 2008 Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Zaballos, MA , Garcia, B, Santisteban, P . Mol. Endocrinol. - 22 (5) : 1183-1199 (PMID: 18202153) (doi:10.1210/me.2007-0093)
1 Dec | 2005 DARPP-32 (dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal phosphoprotein) is essential for the maintenance of thyroid differentiation. García-Jiménez, C, Zaballos, MA , Santisteban, P . Mol. Endocrinol. - 19 (12) : 3060-3072 (PMID: 16020482) (doi:10.1210/me.2005-0129)